InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Kelly Paul Edward, Director. Insider active across 1 company, notably Relmada Therapeutics, INC.. In total, 3 filings have been published. History available since 3 January 2022. The latest transaction was filed on 4 April 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations3 total
10,000 shares@ US$3.240.0041% mcap20.6% of flowCommon StockSEC:0001213900-22-018223:0
20,000 shares@ US$3.240.0079% mcap100.0% of flowCommon StockSEC:0001213900-22-000761
20,000 shares@ US$3.240.0079% mcap39.7% of flowCommon StockSEC:0001213900-22-000761:0
3 of 3 declarations
About Kelly Paul Edward
Paul Edward Kelly is a Board Member of Relmada Therapeutics, Inc., a biotechnology company. As a board member, he participates in overseeing the company's activities and making strategic decisions. His expertise in the biotechnology field is valuable for guiding Relmada's initiatives.
